drug · small molecule
GSK-101
Phase 2updated 5mo agoby $GSK GSK plc🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 5 investigational indications.
targets
Sodium channel protein type 9 subunit alpha
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that